Report cover image

2026 Global: Minimally Invasive Surgical Devices Market -Competitive Review (2032) report

Publisher PerryHope Partners
Published Apr 15, 2025
Length 32 Pages
SKU # PHP21163663

Description

The 2026 Global: Minimally Invasive Surgical Devices Market-Competitive Review (2032) report features the global market size and projected growth/decline data for the period 2021 and 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.

Within the Minimally Invasive Surgical Devices Market, leading global players shape product development, clinical adoption, and distribution across diverse specialties. Intuitive Surgical, headquartered in Sunnyvale, United States, remains the foremost force in robotic-assisted procedures with the da Vinci platform, influencing workflow integration, training, and outcomes. Medtronic plc, based in Dublin, Ireland, complements this with broad endoscopic, imaging, and energy solutions that enable surgeons to perform complex minimally invasive operations with precision. Stryker Corporation, headquartered in Kalamazoo, United States, supplies visualization systems, endoscopic instruments, and access platforms employed across general, urologic, and gynecologic procedures. Johnson & Johnson, anchored by Ethicon and related brands, is headquartered in New Brunswick, United States, and integrates suturing, energy devices, and minimally invasive robotics to support perioperative care. Boston Scientific, based in Marlborough, United States, contributes through endoscopy tools, imaging enhancements, and interventional devices that complement surgical suites and outpatient settings across global hospital networks today.

Olympus Corporation, headquartered in Tokyo, Japan, anchors endoscopy and diagnostic visualization with a broad portfolio of imaging platforms, flexible scopes, and related instruments that enable minimally invasive access in GI, respiratory, and gynecologic care. Karl Storz SE & Co. KG, based in Tuttlingen, Germany, is renowned for its comprehensive line of rigid and flexible endoscopes, visualization systems, and specialized accessories that support routine laparoscopy, arthroscopy, and urology. B. Braun Melsungen AG, headquartered in Melsungen, Germany, delivers surgical access components, irrigation and suction systems, and disposable devices that sustain safe MIS workflows across larger hospital settings. Zimmer Biomet Holdings, headquartered in Warsaw, United States, extends MIS capabilities through image-guided navigation, soft tissue resection tools, and minimally invasive implant platforms that complement both orthopedics and general surgery. ConMed Corporation, based in Utica, United States, offers endoscopy solutions, electrosurgical devices, and visualization products used in a wide array of minimally invasive procedures globally.

Collectively, these ten entities form the core of the global minimally invasive surgical devices ecosystem, driving innovation, regulatory navigation, and value-based care adoption. They invest heavily in robotics, advanced imaging, energy devices, and raw materials, while expanding training networks and evidence generation to support procedural efficiency and patient outcomes. Geographic distribution of headquarters—spanning North America, Europe, and Asia—reflects the market’s transcontinental reach and the importance of regional regulatory alignment, reimbursement strategies, and hospital procurement practices. Strategic acquisitions, partnerships with academic centers, and the integration of digital health capabilities further shape competitive dynamics, enabling faster dissemination of intraoperative guidance, remote mentoring, and data-driven performance tracking. As clinical preferences evolve toward less invasive, more precise interventions, these firms collectively push toward standardized interoperability, streamlined supply chains, and sustainable cost models that benefit surgeons, patients, and health systems alike. Ongoing competition will hinge on evidence, patient access, and cross-border scalability in future markets.

Table of Contents

32 Pages
1.0 Scope of Report and Methodology
2.0 Market SWOT Analysis and Players
2.1 Market Definition
2.2 Market Segments
2.3 Market Strengths
2.4 Market Weaknesses
2.5 Market Threats
2.6 Market Opportunities
2.7 Major Players
3.0 Competitive Analysis
3.1 Market Player 1
3.2 Market Player 2
3.3 Market Player 3
3.4 Market Player 4
3.5 Market Player 5
3.6 Market Player 6
3.7 Market Player 7
3.8 Market Player 8
3.9 Market Player 9
3.10 Market Player 10
4.0 Comparative Business Strategies
4.1 Comparative Business Strategies of Player 1 and 2
4.2 Comparative Business Strategies of Player 1 and 3
4.3 Comparative Business Strategies of Player 1 and 4
4.4 Comparative Business Strategies of Player 2 and 3
4.5 Comparative Business Strategies of Player 2 and 4
4.6 Comparative Business Strategies of Player 3 and 4
5.0 Appendix

Search Inside Report

How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.